Salute e Benessere

Cell Therapy Technologies Market worth $7.8 Billion | MarketsandMarkets

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=213334978 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=213334978 Browse in-depth TOC on "Cell Therapy Technologies Market"210 - Tables 49 - Figures 236 - Pages Cell Therapy Technologies Market Scope: The cell processing segment accounted for the largest share of the process segment in the cell therapy technologies market in 2022...
PR Newswire
27/07/2023

Orion Corporation: Managers' transactions – Kari Jussi Aho

ORION CORPORATIONMANAGERS' TRANSACTIONS27 JULY 2023 at 17.15 EEST Orion Corporation: Managers' transactions – Kari Jussi Aho Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.Orion Oyj - Managers' Transactions____________________________________________Person subject to...
Nasdaq GlobeNewswire
27/07/2023

Akari Therapeutics Granted Nomacopan Orphan Drug Designation from the European…

NEW YORK and LONDON, July27, 2023(GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced that the European Commission granted orphan drug designation to nomacopan as a treatment in hematopoietic stem cell transplantation following the European Medicines Agency positive opinion in June. Akari is currently conducting a registrational Phase 3 study of nomacopan in...
Nasdaq GlobeNewswire
27/07/2023

Norgine Expands Scientific Engagement with Veeva Link Key People

"At Norgine, we are dedicated to bringing life-changing medicines to patients with unmet needs faster," said Dr. Jonathan Jones, vice president of medical affairs at Norgine. "Early engagement with key experts creates a deep understanding of treatments to reach patients most effectively. Veeva Link Key People helps us identify emerging and existing thought leaders and their scientific communities to make each interaction relevant to patient needs from the start." "At…
PR Newswire
27/07/2023

IBA Notice of Half Year 2023 Results and Conference Call

HY23 results meeting to take place as a hybrid event onThursday, 31 August 2023 at 3 pm CEST Louvain-la-Neuve, Belgium, 27 July 2023- IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, announces today that it will publish its consolidated results for the half year 2023 onThursday, 31 August 2023 at 7 am CEST.Conference Call Information Olivier Legrain, Chief Executive Officer, and Soumya Chandramouli, Chief Financial...
Nasdaq GlobeNewswire
27/07/2023

Clarivate Enhances Patient Data Intelligence Solution with Addition of German…

CPDI is the first supplier of this data product, reinforcing Clarivate's position as a leading provider of real-world data solutions in Europe. Sourced from prescribing modules from hospital EHR software, showing treatments prescribed and administered in the hospital setting, the insights capture German in-patient and out-patient care, in an aggregated, anonymised manner. CPDI is the first supplier of this data product, reinforcing Clarivate's position as a leading provider of real-world data...
PR Newswire
27/07/2023

InSilicoTrials and Axoltis Pharma Collaborate to Advance Therapeutic Solutions…

The primary focus of this partnership is to utilize the InSilicoTrials' platform and leverage its InSilicoNEURO suite, which encompasses a variety of mechanistic CNS models. More specifically, the models within InSilicoNEURO will be used to assess the impact of Axoltis' drug candidate on virtual patients with different conditions, including Amyotrophic Lateral Sclerosis (ALS), Parkinson's Disease and Multiple sclerosis (MS). Mechanistic CNS models are designed to simulate the physiological and…
PR Newswire
27/07/2023

Indivior Announces Q2/H1 2023 Financial Results

There will be a live webcast presentation at 13:00 BST (8:00 am EST) hosted by Mark Crossley, CEO. The details are below. There will be a live webcast presentation at13:00 BST( 8:00 am EST ) hosted byMark Crossley, CEO. The details are below. Webcast link:https://edge.media-server.com/mmc/p/z4yh2znf Participants may access the presentation telephonically by registering with the following link:https://register.vevent.com/register/BI80255ae130d847e3944c2584e201ae3e (Please...
PR Newswire
27/07/2023

NEC laboratories advances therapeutic cancer vaccine research with new AI model…

Dr. Pierre Machart, Senior Research Scientist at NEC Laboratories Europe, explains: "Almost any neoantigen arising from cancer mutations has some potential to elicit an immune response and be used in the design of an immunotherapy cancer vaccine. But identifying the neoantigens that are most effective can be extremely challenging." Dr.Pierre Machart, Senior Research Scientist at NEC Laboratories Europe, explains: "Almost any neoantigen arising from cancer mutations has some…
PR Newswire
27/07/2023

EssilorLuxottica announces launch of share buyback program

EssilorLuxottica announces launch of share buyback programCharenton-le-Pont, France (27July 2023- 08:00 am CEST)– EssilorLuxottica announces the launch of its share buyback program reflecting the Group's confidence in its value creation and long-term prospects.With a view to implementing this share buyback program, EssilorLuxottica has granted a mandate to an investment services provider for the purchase of up to 3,500,000 EssilorLuxottica shares, depending on...
Nasdaq GlobeNewswire
27/07/2023

Groupe Casino: Second-quarter 2023 net sales and first-half 2023 results

Second-quarter 2023 net sales and first-half 2023 results Consolidated net sales of €5.5bn in Q2 2023 (down -1.2% LFL) France Retail net sales down -4.2% on a LFL basis, reflecting growth in the Parisian and convenience banners (+2.6% LFL) and a decline in hypermarket and supermarket net sales (-15.3% LFL), including the impact of price adjustments LFL growth of +7.6% in Latin America, with good performances at GPA and Grupo ÉxitoFirst-half earnings EBITDA at...
Nasdaq GlobeNewswire
27/07/2023

[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong growth in both…

Excluding COVID-19 products,Groupsales increase strongly by 8% 1at constant exchange rates (CER) In line with the expected declining demand for COVID-19 products,Groupsales decrease 2% (-8% in Swiss francs) Pharmaceuticals Divisionsales grow strongly by 8% due to continued high demand for newer medicines; new eye medicine Vabysmo is the strongest growth driver Diagnostics Division's base businesscontinues its good growth momentum with an increase of 6%, whiletotal...
Nasdaq GlobeNewswire
27/07/2023

Ipsen delivers solid H1 2023 results and upgrades its full-year guidance

Paris , France:27 July 2023Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, presents today its financial results for the first half of 2023. H1 2023 total sales up by 7.4% at CER 1(7.2% as reported), with growth-platforms' 2sales increasing by 17.7% 1and a strong contribution from newly acquired medicines, Bylvay® (odevixibat) and Tazverik ®(tazemetostat). Somatuline ®(lanreotide) sales, now comprising around a third of the...
Nasdaq GlobeNewswire
27/07/2023

Dementia Market to Grow Rapidly, Estimates DelveInsight | Key Companies Active…

Key Takeaways from the Dementia Market Report Key Takeaways from the Dementia Market Report Discover which therapies are expected to grab the major dementia market share @Dementia Market Report Dementia Overview Dementia is a complex neurological condition characterized by a decline in cognitive abilities, affecting memory, thinking, behavior, and the ability to perform everyday tasks. It is not a specific disease but rather an umbrella term for a group of symptoms that are...
PR Newswire
26/07/2023

Jazz Pharmaceuticals to Report 2023 Second Quarter Financial Results on August…

Interested parties may access the live audio webcast via the Investors section of the Jazz Pharmaceuticals website at https://investor.jazzpharma.com/investors/events-presentations. To ensure a timely connection, it is recommended that participants register at least 15 minutes prior to the scheduled webcast. Interested parties may access the live audio webcast via the Investors section of the Jazz Pharmaceuticals website athttps://investor.jazzpharma.com/investors/events-presentations...
PR Newswire
26/07/2023

Information on the Total Number of Voting Rights (Denominator) following…

Regulated Information - Denominator Atlas Special Opportunities, LLChas converted 6convertible bonds in Oxurion resulting in a EUR 150 ,000capital increase. This is part of Atlas Special Opportunities, LLC's EUR 20 million Capital Commitment1 that will allow Oxurion to focus on progressing its novel and differentiated back of the eye drug candidate targeting potential market opportunities of over USD 5billion.Leuven, BELGIUM ,Boston, MA, US–...
Nasdaq GlobeNewswire
26/07/2023

Oxurion Receives Transparency Notifications from Atlas Special Opportunities LL

Regulated InformationLeuven, BELGIUM, Boston, MA, US – July 26 , 2023 – 7 .00PM CETOxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, today announced that, pursuant to Belgian Transparency legislation 1it has received transparency notifications as follows: Oxurion received a first transparency notification on July 25,...
Nasdaq GlobeNewswire
26/07/2023

Stem Cell Manufacturing Market worth $21.8 Billion | MarketsandMarkets

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=70743403 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=70743403 Browse in-depth TOC on "Stem Cell Manufacturing Market"304 - Tables43 - Figures 283 - Pages Stem Cell Manufacturing Market Scope: Consumables products accounted for the largest share of the stem cell manufacturing market. Among the products, the stem cell...
PR Newswire
26/07/2023

Healthcare Distribution Market size worth $ 1430.09 Billion, Globally, by 2030…

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=290473 Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=290473 Browse in-depth TOCon" Healthcare Distribution Market " 202 - Pages 126 – Tables 37 – Figures Enhancing Access and Efficiency in the Healthcare Distribution Market with Technology and Emerging Markets The goal of the healthcare distribution sector is to lessen patients' reliance on...
PR Newswire
26/07/2023

UPPAbaby Partners with Former Pro-Soccer Player, Leslie Osborne, on Brand…

Experience the full interactive Multichannel News Release here: https://www.multivu.com/players/English/9185752-uppababy-soccer-community-leslie-osborne-brand-campaign/ Experience the full interactive Multichannel News Release here:https://www.multivu.com/players/English/9185752-uppababy-soccer-community-leslie-osborne-brand-campaign/ "When UPPAbaby approached me to share my story as a mom, former pro-athlete and businesswoman and knowing what they stood for as a company, the partnership...
PR Newswire
26/07/2023

CartiHeal Announces First Commercial Implantation of Agili-C™ in the US

Dr. Zaslav commented, "Agili-C is a technology I and others in the surgical community have been watching and waiting on for over 10 years. It is a novel implant supported by 4-years of data and counting from the multinational, randomized and controlled IDE clinical trial. Agili-C offers a cost efficient, off-the-shelf implant to fill an unmet need in my clinical practice." Dr. Zaslav commented, "Agili-C is a technology I and others in the surgical community have been watching and…
PR Newswire
26/07/2023

Global Psychedelic Therapeutics Market Size Expected To Reach $13.29 Billion By…

Insight Ace Analytic continued: "In 2021, North America led the market. Major determinants, such as the increase in the frequency of depression and other mental diseases and the rapid advancement of research, are driving the market growth. The population's increased awareness of anxiety and mental health is anticipated to stimulate regional growth further. The Asia-Pacific region is anticipated to see a considerable growth rate over the projected period as a result of the growing awareness…
PR Newswire
26/07/2023

Latest Research Evaluating Clinical Benefits of VASCEPA®/VAZKEPA® (icosapent…

The accepted abstracts will be presented by international academic collaborators, including Dr. Deepak L. Bhatt MD, MPH, Director of Mount Sinai Heart and the Dr. Valentin Fuster Professor of Cardiovascular Medicine, based on research or analyses sponsored by Amarin.Featured Amarin-supported abstracts to be presented at ESC Congress 2023 include:Abstract Sessions Oral PresentationSession: Remnant cholesterol and triglyceride-rich lipoproteins in atherosclerosis progression and...
Nasdaq GlobeNewswire
26/07/2023

Veeva Pulse Uncovers Field Medical Engagement Drives 1.5x Increase in Treatment…

Scientific engagement with KOLs has a lasting impact on new treatment adoption and most KOLs are asking for more interactions with MSLs. Yet, 70% only engage with one company's field medical team. The lack of breadth in KOL engagement indicates a need for greater field planning and connected insights across the organization to identify and prioritize engagement with key experts. Scientific engagement with KOLs has a lasting impact on new treatment adoption and most KOLs are asking for more...
PR Newswire
26/07/2023
Altri  Comunicati